Results 151 to 160 of about 188,190 (277)
Criteria for Control and Remission of Respiratory Allergic Disease With Allergen Immunotherapy: A Delphi Consensus. [PDF]
González-Mancebo E +11 more
europepmc +1 more source
Background: Atopic dermatitis (AD) is a common chronic, pruritic and inflammatory skin disease in both humans and dogs. In people, AD is increasingly recognised as a systemic inflammatory disease in which immune dysregulation drives chronic inflammation extending beyond the skin, particularly in moderate‐to‐severe disease. Whether a comparable systemic
Ina Herrmann +2 more
wiley +1 more source
Clinical Evaluation of Allergen Immunotherapy for Allergic Rhinitis. [PDF]
Catamerò F +10 more
europepmc +1 more source
Background: Currently used methods for the interpretation of intradermal allergen test results either ignore the erythema of the wheals (objective method) or evaluate it subjectively (subjective method, and global wheal score [GWS]). Objectives: To compare the efficacy of GWSs in differentiating between wheals induced by intradermal injection of a ...
Ana Petak +5 more
wiley +1 more source
Dupilumab Combined With House Dust Mite Allergen Immunotherapy for Atopic Dermatitis: A Systematic Review and Meta-Analysis. [PDF]
Lian J, Ren L, Liang J, Guo S.
europepmc +1 more source
ABSTRACT Aim To evaluate the association between reported symptoms upon exposure to airborne allergens and sensitization to the corresponding allergen. Method In a population‐based cohort, 1647 children aged 12 years were interviewed about symptoms from eyes, nose and lower airways upon exposure to birch, timothy, cat, dog, and horse, and were ...
E. Rönmark +5 more
wiley +1 more source
Cytokines and immunologic checkpoint molecules in predicting success of allergen immunotherapy. [PDF]
Berge M +4 more
europepmc +1 more source
Background: Faecal microbiota transplantation (FMT) is an established therapy for gastrointestinal disease, yet its role in canine atopic dermatitis (cAD) remains unclear. Hypothesis/Objectives: We hypothesised that adjunctive FMT improves clinical severity and reduces symptomatic medication use in dogs with cAD.
Vera Felten +9 more
wiley +1 more source
TNF Pathway-Mediated Tolerogenic T-Cell Trajectory Driven by Allergen Immunotherapy. [PDF]
Charles HS +20 more
europepmc +1 more source

